Skip to main content
. 2003 Jan;23(1):104–118. doi: 10.1128/MCB.23.1.104-118.2003

FIG. 3.

FIG. 3.

Inhibition of FKHRL1 activity by activated androgen receptor. (A) Inhibition of FKHRL1 activity by androgens in DU145 cells. Cells were transfected with 0.2 μg of pCMVhAR, 0.2 μg of pCMVβ, 0.5 μg of FHRE-Luc, and 0.1 μg of HA-FKHRL1-WT. Transfected cells were treated and FKHRL1 activity was determined as for Fig. 1B. (B) Inhibition of FKHRL1 activity by androgens through endogenous androgen receptor (AR) in LNCaP cells. Cells were transfected as for panel A except that HA-FKHRL1-MT was used in the place of HA-FKHRL1-WT and no pCMVhAR was included in the transfection. Transfected cells were treated and FKHRL1 activity was determined as for Fig. 1B.